AstraZeneca Plc Medical Tablets As U.K. Pharma Company Rejects Pfizer's $98.7 Billion Bid

AstraZeneca Paludrine 100mg tablets, produced by AstraZeneca Plc, sit on a blister pack in this arranged photograph taken in London, U.K., on Tuesday, April 29, 2014. Pfizer Inc., the biggest U.S. drugmaker, plans to renew discussions to acquire AstraZeneca, said people familiar with the matter. Photographer: Simon Dawson/Bloomberg via Getty Images
AstraZeneca Paludrine 100mg tablets, produced by AstraZeneca Plc, sit on a blister pack in this arranged photograph taken in London, U.K., on Tuesday, April 29, 2014. Pfizer Inc., the biggest U.S. drugmaker, plans to renew discussions to acquire AstraZeneca, said people familiar with the matter. Photographer: Simon Dawson/Bloomberg via Getty Images
AstraZeneca Plc Medical Tablets As U.K. Pharma Company Rejects Pfizer's $98.7 Billion Bid
PURCHASE A LICENSE
How can I use this image?
$375.00
USD
Getty ImagesAstraZeneca Plc Medical Tablets As U.K. Pharma Company Rejects..., News PhotoAstraZeneca Plc Medical Tablets As U.K. Pharma Company Rejects..., News PhotoAstraZeneca Plc Medical Tablets As U.K. Pharma Company Rejects... Get premium, high resolution news photos at Getty ImagesProduct #:487415119
$499$175
Getty Images
In stock

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
487415119
Collection:
Bloomberg
Date created:
April 29, 2014
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
UK ASTRAZENECA